As the Pfizer-BioNTech and Moderna vaccines have not yet been tested on children below the ages of 16 and 18, respectively, there are no current recommendations regarding this pediatric population. If your child is 16 or older, they may be eligible for the Pfizer-BioNTech vaccine. Please click here to view COVID-19 vaccination information for MS patients.
